Physician profile
David E Dominguez
NPI 1467694521
$6,329.74
in general payments reported to CMS, 2019-2025
14 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,866 · 2020: $329 · 2021: $161 · 2022: $11.66 · 2023: $129 · 2024: $536 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Travel and Lodging: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.09 |
| Travel and Lodging | $399.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,134.00 | 2019-2025 | Mako |
| Arthrex, INC. | $502.60 | 2024-2025 | |
| Vericel Corporation | $183.29 | 2023-2025 | Maci |
| Miach Orthopaedics, INC. | $139.46 | 2024 | |
| Depuy Synthes Sales INC. | $133.06 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $37.68 | 2020-2024 | Exparel |
| Trice Medical, INC. | $34.23 | 2024 | |
| Smith+Nephew, INC. | $30.13 | 2019 | |
| Reel Surgical, INC. | $30.00 | 2024 | |
| Nevro Corp. | $28.54 | 2020 | |
| Theragen, INC. | $28.12 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.90 | 2024 | |
| Medtronic, INC. | $17.07 | 2025 | Interstim |
| Embody, INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dominguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.